Business
VMS Rehab Systems Inc. Reports On Drug Development At BioPharmcor Drug Unit
VMS Rehab Systems Inc. Reports On Drug Development At BioPharmcor Drug Unit.
About this update from Vms Rehab Systems
[{"type":"text","content":"\n\n\n\nVMS Rehab Systems Inc. Reports On Drug Development At BioPharmcor Drug Unit\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nVMS Rehab Systems Inc. Reports On Drug Development At BioPharmcor Drug Unit\nPR Newswire\nOTTAWA, Ontario, Feb. 25, 2016\n\n\n\nOTTAWA, Ontario, Feb. 25, 2016 /PRNewswire/ -- VMS Rehab Systems Inc. (www.vmsrehabsystemsinc.com) reported today on the current status of a generic drug development program at its majority owned Dutch based pharmaceutical, BioPharmcor BV (www.biopharmcor.com).  The Company confirmed that BioPharmcor is in the final stages of development and testing of its generic tadalafil product prior to entering an intensive period of human clinical trials. The clinical trials are intended to demonstrate the bioequivalence of the BioPharmcor generic tadalafil drug against the marketed name brand patented product, to support submissions for market approval in a number of countries.\n\nBioPharmcor's tadalafil is intended as a first line treatment for men suffering from Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH). It is estimated that the market for ED drug remedies is approximately $4.5 billion worldwide. \n\nA spokesperson for BioPharmcor explains that, \"BioPharmcor's generic tadalafil will be sold at significantly lower prices than the approved patented drug, making BioPharmcor's generic drug accessible to a broad constituency of men in global markets who currently cannot afford to pay for the higher priced name brand product.\"\n\nAmsterdam based BioPharmcor BV, is currently formulating and developing a line of drug products keyed to advancing men's health. The company has two operating subsidiaries, BioPharmcor Sp z .o.o. in Warsaw, Poland and BioPharmcor Inc, in Ottawa, Canada.\n\nVMS Rehab Systems Inc. was established as a Canadian incorporated company in 1989. In addition to controlling BioPharmcor BV, VMS Rehab Systems Inc. has been active in the home health market in North America for the past 18 years. The company operates through its office in Ottawa and affiliated BioPharm...